Immediate Impact
7 standout
Citing Papers
Cell–cell communication: new insights and clinical implications
2024 Standout
Epigenetic modification of m6A regulator proteins in cancer
2023 Standout
Works of Stephen Grossman being referenced
Abstract 3079: Pharmacodynamic evaluation of the novel SUMOylation inhibitor TAK-981 in a mouse tumor model
2019
Abstract 3252: TAK-981: A first in class SUMO inhibitor in Phase 1 trials that promotes dendritic cell activation, antigen-presentation, and T cell priming
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stephen Grossman | 28 | 29 | 51 | 8 | 63 | |
| Andrew R. Patterson | 25 | 16 | 28 | 6 | 56 | |
| Zhenkun Zhuang | 15 | 21 | 40 | 12 | 69 | |
| Chin Leng Tan | 36 | 38 | 35 | 9 | 72 | |
| Meghan E. Bushway | 50 | 38 | 25 | 7 | 75 | |
| Sarah M. Shin | 22 | 32 | 25 | 9 | 62 | |
| Alexei Hernandez | 23 | 36 | 26 | 9 | 66 | |
| Kumiko Ayukawa | 28 | 22 | 58 | 5 | 75 | |
| Sophie E. Willis | 16 | 73 | 67 | 7 | 94 | |
| Tienan Yi | 37 | 43 | 23 | 11 | 72 | |
| Hui Yi Chew | 16 | 33 | 30 | 8 | 84 |
All Works
Loading papers...